Tri-Legest Fe (ethinyl estradiol / norethindrone) Drug Interactions
A total of 402 drugs are known to interact with Tri-Legest Fe (ethinyl estradiol / norethindrone).
- 36 major drug interactions
- 321 moderate drug interactions
- 45 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Tri-Legest Fe (ethinyl estradiol / norethindrone) and the medicines listed below.
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Flexeril (cyclobenzaprine)
- folic acid
- ibuprofen
- Levaquin (levofloxacin)
- loratadine
- Lortab (acetaminophen / hydrocodone)
- multivitamin
- omeprazole
- prednisone
- Protonix (pantoprazole)
- Seroquel (quetiapine)
- sertraline
- spironolactone
- Topamax (topiramate)
- trazodone
- Valium (diazepam)
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
Tri-Legest Fe (ethinyl estradiol / norethindrone) alcohol/food interactions
There are 8 alcohol/food interactions with Tri-Legest Fe (ethinyl estradiol / norethindrone)
Tri-Legest Fe (ethinyl estradiol / norethindrone) disease interactions
There are 23 disease interactions with Tri-Legest Fe (ethinyl estradiol / norethindrone) which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Tri-Legest Fe (ethinyl estradiol / norethindrone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Pricing & Coupons
- Drug class: contraceptives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
